NLRP3 and ischemic stroke: In a murine model of ischemic stroke, sinomenine (10–20 mg/kg, ip) provided salutary effect by attenuating expression of NLRP3 and ASC, decrementing cleaved caspase-1 and IL-1β levels, as well as IL-6, IL-18, and TNF-α concentrations [211].